ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The E3 ubiquitin ligase RBCK1: Implications in the tumor immune microenvironment and antiangiogenic therapy of glioma

Guo, Jing; Sun, Donglin; Zhang, Junwei; Guo, Jie; Wu, Zhenpeng; Chen, Yongzhen; Xu, Yujie; Zhou, Desheng; Cui, Yachao; Mo, Qi; Li, Yingchang; Zhao, Ting*; You, Qiang*复旦大学; 广州医学院; 南方医科大学
Computational and Structural Biotechnology Journal2023DOI: 10.1016/j.csbj.2023.10.020
8阅读
引用收藏
分享

摘要

E3 ubiquitin ligases (E3s) play a pivotal role in regulating the specificity of protein ubiquitination, and their significant functions as regulators of immune responses against tumors are attracting considerable interest. RBCK1-an RBR E3 ligase-is involved in immune regulation and tumor development. However, the potential effect of RBCK1 on glioma remains enigmatic. In the present study, we performed comprehensive analyses of multilevel data, which disclosed distribution characteristics of RBCK1 in pan-cancer, especially in glioma. Functional roles of RBCK1 were further confirmed using immunohistochemistry, cell biological assays, and xenograft experiments. Aberrant ascending of RBCK1 in multiple types of cancer was found to remodel the immunosuppressive microenvironment of glioma by regulating immunomodulators, cancer immunity cycles, and immune cell infiltration. Notably, the MES-like/RBCK1High cell population, a unique subset of cells in the microenvironment, suppressed T cell-mediated cell killing in glioma. Elevated expression levels of RBCK1 suggested a glioma subtype characterized by immunosuppression and hypo-responsiveness to immunotherapy but manifesting surprisingly increased responses to anti-angiogenic therapy. In conclusion, anti-RBCK1 target therapy might be beneficial for glioma treatment. Moreover, RBCK1 assisted in predicting molecular subtypes of glioma and response rates of patients to different clinical treatments, which could guide personalized therapy.

学科与关键词

关键词
RBCK1Tumor immune microenvironmentAntiangiogenic therapyBiomarkerGlioma
相关
加载中…
  • Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme
    Mu, Long; Han, Zhibin; Yu, Shengkun; Wang, Aowen; Chen, Dongjiang; Kong, Sijia; Gu, Yifei; Xu, Lin; Liu, Axiang; Sun, Ruohan*; Long, Yu*Frontiers in Immunology, 2022, 13: 842524.被引 2
  • Cancer cell intrinsic TIM-3 induces glioblastoma progression
    Guo, Qing; Shen, Shuai; Guan, Gefei; Zhu, Chen; Zou, Cunyi; Cao, Jingyuan; Cheng, Wen; Xu, Xiaoyan; Yu, Juanhan; Lin, Zhiguo; Wang, Guoli; Chen, Ling; Cheng, Peng*; Wu, Anhua*iScience, 2022, 25(11): 105329.被引 9
  • Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas
    Liu, Zhendong; Cheng, Xingbo; Lin, Shaochong; Han, Zhibin; Jin, Haoran; Luan, Zheyu; Li, Pengxu; Liang, Wenjia; Qian, Rongjun*; Gao, Yanzheng*Cellular and Molecular Neurobiology, 2023, 43(1): 409-422.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Computational and Structural Biotechnology Journal
发表日期
2023
卷期
第 21 卷
页码
5212-5227
DOI
10.1016/j.csbj.2023.10.020
成果收录
SCIE
资助标注
Guangzhou key medical discipline construction project, Jiangsu medical scientific research project of Jiangsu Health Commission; National Natural Science Foundation of China [81870409, 81671543]; Jiangsu Province Capability Improvement Project through Science, Technology and Education, Jiangsu Provincial Medical Key Discipline Cultivation Unit [JSDW202235]; 789 Outstanding Talent Program of SAHNMU [789ZYRC202070102]; Project of Educational Commission of Guangdong Province of China [2021KCXTD023]; China Postdoctoral Science Foundation [2023M730675]; Shanghai Sailing Program [23YF1406800]

作者

  • G

    Guo, Jing (第一作者)

    guangzhou med univ

  • S

    Sun, Donglin

    southern med univ

查看全部 13 位作者收起作者
  • Z

    Zhang, Junwei

    guangzhou med univ

  • G

    Guo, Jie

    guangzhou med univ

  • W

    Wu, Zhenpeng

    guangzhou med univ

  • C

    Chen, Yongzhen

    2 · nanjing med univ

  • X

    Xu, Yujie

    guangzhou med univ

  • Z

    Zhou, Desheng

    guangzhou med univ

  • C

    Cui, Yachao

    guangzhou med univ

  • M

    Mo, Qi

    guangzhou med univ

  • L

    Li, Yingchang

    guangzhou med univ

  • Z

    Zhao, Ting (通讯)

    fudan univ

  • Y

    You, Qiang (通讯)

    guangzhou med univ · 2 · nanjing med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417